BACKGROUND/AIMS: To evaluate the efficacy of Direct Antiviral Agents (DAA)-based regimen in HBsAg/anti-HCV/HCV-RNA-positive patients (pts) in terms of sustained virolgical response for HCV and of reactivation of HBV infection. METHODS: In a multicentric, prospective study we enrolled 29HBsAg/anti-HCV-positive pts treated with DAA . At the time...